The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Milk Oligosaccharides (HMO)-Global Market Insights and Sales Trends 2024
Synopsis
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
The global Human Milk Oligosaccharides (HMO) market size is expected to reach US$ 1227.5 million by 2029, growing at a CAGR of 14.5% from 2023 to 2029. The market is mainly driven by the significant applications of Human Milk Oligosaccharides (HMO) in various end use industries. The expanding demands from the Infant Formula and Others, are propelling Human Milk Oligosaccharides (HMO) market. 2'-FL & 3-FL, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the LNT & LNnT, etc. segment is estimated at % CAGR for the next seven-year period.
Global key players of human milk oligosaccharides (HMO) include Abbott, Glycom, Chr. Hansen (Jennewein), etc. The top three players hold a share about 81%. North America is the largest market, has a share about 47%, followed by Europe and Asia-Pacific, with share 33% and 19%, separately.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Milk Oligosaccharides (HMO) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Milk Oligosaccharides (HMO) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Milk Oligosaccharides (HMO) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Milk Oligosaccharides (HMO) covered in this report include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA and ZuChem, etc.
The global Human Milk Oligosaccharides (HMO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
Global Human Milk Oligosaccharides (HMO) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Milk Oligosaccharides (HMO) market, Segment by Type:
2'-FL & 3-FL
LNT & LNnT, etc.
Global Human Milk Oligosaccharides (HMO) market, by Application
Infant Formula
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
The global Human Milk Oligosaccharides (HMO) market size is expected to reach US$ 1227.5 million by 2029, growing at a CAGR of 14.5% from 2023 to 2029. The market is mainly driven by the significant applications of Human Milk Oligosaccharides (HMO) in various end use industries. The expanding demands from the Infant Formula and Others, are propelling Human Milk Oligosaccharides (HMO) market. 2'-FL & 3-FL, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the LNT & LNnT, etc. segment is estimated at % CAGR for the next seven-year period.
Global key players of human milk oligosaccharides (HMO) include Abbott, Glycom, Chr. Hansen (Jennewein), etc. The top three players hold a share about 81%. North America is the largest market, has a share about 47%, followed by Europe and Asia-Pacific, with share 33% and 19%, separately.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Milk Oligosaccharides (HMO) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Milk Oligosaccharides (HMO) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Milk Oligosaccharides (HMO) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Milk Oligosaccharides (HMO) covered in this report include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA and ZuChem, etc.
The global Human Milk Oligosaccharides (HMO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
Global Human Milk Oligosaccharides (HMO) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Milk Oligosaccharides (HMO) market, Segment by Type:
2'-FL & 3-FL
LNT & LNnT, etc.
Global Human Milk Oligosaccharides (HMO) market, by Application
Infant Formula
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Milk Oligosaccharides (HMO) Market Overview
1.1 Human Milk Oligosaccharides (HMO) Product Overview
1.2 Human Milk Oligosaccharides (HMO) Market Segment by Type
1.2.1 2'-FL & 3-FL
1.2.2 LNT & LNnT, etc.
1.3 Global Human Milk Oligosaccharides (HMO) Market Size by Type
1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size Overview by Type (2018-2029)
1.3.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2018-2023)
2 Global Human Milk Oligosaccharides (HMO) Market Competition by Company
2.1 Global Top Players by Human Milk Oligosaccharides (HMO) Sales (2018-2023)
2.2 Global Top Players by Human Milk Oligosaccharides (HMO) Revenue (2018-2023)
2.3 Global Top Players by Human Milk Oligosaccharides (HMO) Price (2018-2023)
2.4 Global Top Manufacturers Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Milk Oligosaccharides (HMO) Market Competitive Situation and Trends
2.5.1 Human Milk Oligosaccharides (HMO) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Milk Oligosaccharides (HMO) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2022)
2.7 Date of Key Manufacturers Enter into Human Milk Oligosaccharides (HMO) Market
2.8 Key Manufacturers Human Milk Oligosaccharides (HMO) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Milk Oligosaccharides (HMO) Status and Outlook by Region
3.1 Global Human Milk Oligosaccharides (HMO) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size by Region
3.2.1 Global Human Milk Oligosaccharides (HMO) Sales in Volume by Region (2018-2023)
3.2.2 Global Human Milk Oligosaccharides (HMO) Sales in Value by Region (2018-2023)
3.2.3 Global Human Milk Oligosaccharides (HMO) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Region
3.3.1 Global Human Milk Oligosaccharides (HMO) Sales in Volume by Region (2024-2029)
3.3.2 Global Human Milk Oligosaccharides (HMO) Sales in Value by Region (2024-2029)
3.3.3 Global Human Milk Oligosaccharides (HMO) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Milk Oligosaccharides (HMO) by Application
4.1 Human Milk Oligosaccharides (HMO) Market Segment by Application
4.1.1 Infant Formula
4.1.2 Others
4.2 Global Human Milk Oligosaccharides (HMO) Market Size by Application
4.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Overview by Application (2018-2029)
4.2.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2018-2023)
5 North America Human Milk Oligosaccharides (HMO) by Country
5.1 North America Human Milk Oligosaccharides (HMO) Historic Market Size by Country
5.1.1 North America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Milk Oligosaccharides (HMO) Sales in Volume by Country (2018-2023)
5.1.3 North America Human Milk Oligosaccharides (HMO) Sales in Value by Country (2018-2023)
5.2 North America Human Milk Oligosaccharides (HMO) Forecasted Market Size by Country
5.2.1 North America Human Milk Oligosaccharides (HMO) Sales in Volume by Country (2024-2029)
5.2.2 North America Human Milk Oligosaccharides (HMO) Sales in Value by Country (2024-2029)
6 Europe Human Milk Oligosaccharides (HMO) by Country
6.1 Europe Human Milk Oligosaccharides (HMO) Historic Market Size by Country
6.1.1 Europe Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Milk Oligosaccharides (HMO) Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Milk Oligosaccharides (HMO) Sales in Value by Country (2018-2023)
6.2 Europe Human Milk Oligosaccharides (HMO) Forecasted Market Size by Country
6.2.1 Europe Human Milk Oligosaccharides (HMO) Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Milk Oligosaccharides (HMO) Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Milk Oligosaccharides (HMO) by Region
7.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Historic Market Size by Region
7.1.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales in Value by Region (2024-2029)
8 Latin America Human Milk Oligosaccharides (HMO) by Country
8.1 Latin America Human Milk Oligosaccharides (HMO) Historic Market Size by Country
8.1.1 Latin America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Milk Oligosaccharides (HMO) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Milk Oligosaccharides (HMO) Sales in Value by Country (2018-2023)
8.2 Latin America Human Milk Oligosaccharides (HMO) Forecasted Market Size by Country
8.2.1 Latin America Human Milk Oligosaccharides (HMO) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Milk Oligosaccharides (HMO) Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Milk Oligosaccharides (HMO) by Country
9.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Historic Market Size by Country
9.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Human Milk Oligosaccharides (HMO) Products Offered
10.1.5 Abbott Recent Development
10.2 Inbiose
10.2.1 Inbiose Company Information
10.2.2 Inbiose Introduction and Business Overview
10.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Inbiose Human Milk Oligosaccharides (HMO) Products Offered
10.2.5 Inbiose Recent Development
10.3 Glycom
10.3.1 Glycom Company Information
10.3.2 Glycom Introduction and Business Overview
10.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Glycom Human Milk Oligosaccharides (HMO) Products Offered
10.3.5 Glycom Recent Development
10.4 Chr. Hansen (Jennewein)
10.4.1 Chr. Hansen (Jennewein) Company Information
10.4.2 Chr. Hansen (Jennewein) Introduction and Business Overview
10.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Products Offered
10.4.5 Chr. Hansen (Jennewein) Recent Development
10.5 Elicityl SA
10.5.1 Elicityl SA Company Information
10.5.2 Elicityl SA Introduction and Business Overview
10.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Products Offered
10.5.5 Elicityl SA Recent Development
10.6 ZuChem
10.6.1 ZuChem Company Information
10.6.2 ZuChem Introduction and Business Overview
10.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 ZuChem Human Milk Oligosaccharides (HMO) Products Offered
10.6.5 ZuChem Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Milk Oligosaccharides (HMO) Industrial Chain Analysis
11.4 Human Milk Oligosaccharides (HMO) Market Dynamics
11.4.1 Human Milk Oligosaccharides (HMO) Industry Trends
11.4.2 Human Milk Oligosaccharides (HMO) Market Drivers
11.4.3 Human Milk Oligosaccharides (HMO) Market Challenges
11.4.4 Human Milk Oligosaccharides (HMO) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Milk Oligosaccharides (HMO) Distributors
12.3 Human Milk Oligosaccharides (HMO) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
